Literature DB >> 12003251

Does apolipoprotein E influence learning and memory in the nondemented oldest old?

A Salo1, R Ylikoski, A Verkkoniemi, T Polvikoski, K Juva, S Rastas, K Kontula, K Kainulainen, L Niinistö, I L Notkola, R Sulkava.   

Abstract

The objective of this study was to analyze the relationship of the apolipoprotein E (apoE) epsilon4 and epsilon2 alleles to learning and memory performances in the nondemented oldest old. Forty-six nondemented persons aged 85 years or over from a randomly selected group of 128 subjects in Vantaa, Finland, were studied. ApoE genotyping was performed using the minisequencing technique. A structured clinical examination and interview were carried out. The test variables studied were learning and memory scores (from the Fuld Object-Memory Evaluation), verbal fluency, and conceptualization (the Similarities subtest of the WAIS-R). We compared apoE-epsilon4 carriers to noncarriers and apoE-epsilon2 carriers to noncarriers. No statistically significant differences were found in any of the test variables. The results failed to confirm the hypotheses that poor cognitive performance is associated with the apoE-epsilon4 allele and good performance with the apoE-epsilon2 allele in the oldest old. This suggests that the apoE alleles do not have a detectable relationship to learning and memory in nondemented very elderly people.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12003251     DOI: 10.1017/s1041610201007864

Source DB:  PubMed          Journal:  Int Psychogeriatr        ISSN: 1041-6102            Impact factor:   3.878


  9 in total

Review 1.  Neuropsychological and neuroimaging changes in preclinical Alzheimer's disease.

Authors:  Elizabeth W Twamley; Susan A Legendre Ropacki; Mark W Bondi
Journal:  J Int Neuropsychol Soc       Date:  2006-09       Impact factor: 2.892

Review 2.  The effects of cholesterol on learning and memory.

Authors:  Bernard G Schreurs
Journal:  Neurosci Biobehav Rev       Date:  2010-05-12       Impact factor: 8.989

3.  In Thai Nationals, the ApoE4 Allele Affects Multiple Domains of Neuropsychological, Biobehavioral, and Social Functioning Thereby Contributing to Alzheimer's Disorder, while the ApoE3 Allele Protects Against Neuropsychiatric Symptoms and Psychosocial Deficits.

Authors:  Sookjaroen Tangwongchai; Thitiporn Supasitthumrong; Solaphat Hemrunroj; Chavit Tunvirachaisakul; Phenphichcha Chuchuen; Natnicha Houngngam; Thiti Snabboon; Ittipol Tawankanjanachot; Yuthachai Likitchareon; Kamman Phanthumchindad; Michael Maes
Journal:  Mol Neurobiol       Date:  2018-01-06       Impact factor: 5.590

Review 4.  Use of genetic variation as biomarkers for Alzheimer's disease.

Authors:  Christiane Reitz; Richard Mayeux
Journal:  Ann N Y Acad Sci       Date:  2009-10       Impact factor: 5.691

Review 5.  Use of genetic variation as biomarkers for mild cognitive impairment and progression of mild cognitive impairment to dementia.

Authors:  Christiane Reitz; Richard Mayeux
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 6.  Endophenotypes in normal brain morphology and Alzheimer's disease: a review.

Authors:  C Reitz; R Mayeux
Journal:  Neuroscience       Date:  2009-04-09       Impact factor: 3.590

7.  Better memory functioning associated with higher total and low-density lipoprotein cholesterol levels in very elderly subjects without the apolipoprotein e4 allele.

Authors:  Rebecca West; Michal Schnaider Beeri; James Schmeidler; Christine M Hannigan; Gary Angelo; Hillel T Grossman; Clive Rosendorff; Jeremy M Silverman
Journal:  Am J Geriatr Psychiatry       Date:  2008-09       Impact factor: 4.105

8.  Brain aging in the oldest-old.

Authors:  A von Gunten; K Ebbing; A Imhof; P Giannakopoulos; E Kövari
Journal:  Curr Gerontol Geriatr Res       Date:  2010-07-25

9.  Microstructural white matter changes, not hippocampal atrophy, detect early amnestic mild cognitive impairment.

Authors:  Lin Zhuang; Perminder S Sachdev; Julian N Trollor; Simone Reppermund; Nicole A Kochan; Henry Brodaty; Wei Wen
Journal:  PLoS One       Date:  2013-03-14       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.